期刊
JOURNAL OF INFECTION AND CHEMOTHERAPY
卷 19, 期 3, 页码 365-380出版社
ELSEVIER
DOI: 10.1007/s10156-013-0599-4
关键词
Guideline; Vancomycin; Therapeutic drug monitoring; MRSA
资金
- Pfizer Japan Inc.
- Astellas Pharma
- Shionogi Co., Ltd.
- MSD KK
- Taisho Toyama Pharmaceutical Co., Ltd.
- Takeda Pharmaceutical Company Limited
- Dainippon Sumitomo Pharma
- Grants-in-Aid for Scientific Research [23591485, 23390037] Funding Source: KAKEN